Research Articles on Tuberculosis from 1940 onwards

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.
Antimicrob Agents Chemother. 2005 Jun;49(6):2218-25.
Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Ethambutol Resistance in Human Isolates ofMycobacterium tuberculosis
Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacteriumtuberculosis from Northwestern Russia: implications for genotypic resistance testing.
J Clin Microbiol. 2002 Oct;40(10):3810-3.
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
Am J Respir Crit Care Med. 2006 Aug 1;174(3):331-8. Epub 2006 May 4.
Ethambutol, a cell wall inhibitor of Mycobacterium tuberculosis, elicits L-glutamate efflux of Corynebacterium glutamicum.
Microbiology. 2005 May;151(Pt 5):1359-68.
Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutolresistance in Mycobacterium tuberculosis.
Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allele-specificPCR assay targeting embB306 mutations.
J Clin Microbiol. 2002 May;40(5):1617-20.
Structural mechanism for rifampicin inhibition of bacterial rna polymerase.
Cell. 2001 Mar 23;104(6):901-12.
Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.
Ann Clin Microbiol Antimicrob. 2006 Feb 15;5:3.
Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru.
Tuber Lung Dis. 1998;79(2):111-8.